🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Healthcare firm Guardian Pharmacy raises $112 million in US IPO

Published 09/25/2024, 11:15 PM
Updated 09/26/2024, 10:30 AM
© Reuters. FILE PHOTO: Morning sunlight falls on the facade of the New York Stock Exchange (NYSE) building after the start of Thursday's trading session in Manhattan in New York City, New York, U.S., January 28, 2021. REUTERS/Mike Segar/File Photo
GRND
-

(Reuters) - Guardian Pharmacy, which provides pharmacy services to long-term healthcare facilities, raised $112 million in its U.S. initial public offering on Wednesday, valuing the company at about $852 million.

The Atlanta, Georgia-based firm priced its offering of 8 million shares of Class A common stock at $14 apiece, the low-end of its targeted range of $14 to $16 each.

The U.S. market for fresh listings is seeing a recovery in investor appetite, boosted by expectations of monetary policy easing by the country's Federal Reserve and market optimism for a soft landing.

Investors have been selective in backing companies, with those burning cash as least favored, after a two-year IPO market downturn that saw poor performance from a raft of recently public high-profile firms.

Guardian Pharmacy, which was founded in 2004, offers a suite of technology-enabled services designed to help residents of long-term health care facilities. It was operating 50 pharmacies serving roughly 174,000 residents, as of June 30.

For the full-year 2023, Guardian Pharmacy's revenue rose to $1.05 billion, compared with $908.9 million a year earlier.

More than two-thirds of the company's annual revenue over the past three years has been generated from residents in assisted living facilities, behavioral health facilities and group homes, the company said in a regulatory filing.

Guardian Pharmacy said the remainder of the revenue is generated from residents of skilled nursing facilities.

It turned a net profit of $37.7 million in 2023 versus $49.7 million a year earlier.

The company's shares will trade on the New York Stock Exchange under the ticker symbol "GRDN."

© Reuters. FILE PHOTO: Morning sunlight falls on the facade of the New York Stock Exchange (NYSE) building after the start of Thursday's trading session in Manhattan in New York City, New York, U.S., January 28, 2021. REUTERS/Mike Segar/File Photo

Raymond James, Stephens and Truist Securities are the underwriters of the offering.

(This story has been corrected to say that the company's valuation is about $852 million, not $869.3 million, in paragraph 1)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.